Shyld AI Raises $13.4 Million to Bring “Active AI” Into Hospital Operations

Healthcare AI startup Shyld AI has raised $13.4 million in seed funding as it looks to expand its real-time operational AI systems across hospitals in the United States. The round was led by Aulis Capital and ranks among the larger seed financings in the emerging healthcare agentic AI sector.

Founded by brothers Mohammad and Morteza Noshad, the company is focused on what it describes as “Active AI” — systems capable of taking direct operational action inside healthcare environments rather than simply generating recommendations or summaries.

Moving Beyond Passive Healthcare AI

Much of today’s healthcare AI ecosystem has centered around administrative automation, ambient listening tools, and clinical documentation assistants. Shyld AI is positioning itself differently by building AI systems that actively monitor and respond to real-world hospital activity in real time.

Its technology is designed to operate inside operating rooms and clinical facilities, where the system can interpret workflow activity such as surgical progression, room turnover timing, staff movement, and procedural bottlenecks. The goal is to reduce delays, improve operating room efficiency, and automate portions of hospital operations that typically require constant human coordination.

The platform also monitors compliance and infection-control processes, areas that remain major operational and financial burdens for hospitals.

Edge AI Inside Hospital Rooms

At the center of the company’s platform is a proprietary AI model called VERTEX, which was built specifically for edge-native deployment in physical healthcare environments.

Rather than depending heavily on cloud infrastructure, the system runs directly on devices located inside hospital rooms. This approach allows the AI to continuously perceive and respond to changing conditions with minimal latency while also reducing concerns around transmitting sensitive healthcare data externally.

Edge AI architectures have become increasingly important in industries where reliability, privacy, and real-time decision-making are critical. In hospital environments, even small delays or interruptions can disrupt workflows and affect patient outcomes, making localized processing especially valuable.

Shyld AI’s infrastructure is designed to function continuously inside clinical environments without requiring extensive integration into hospital IT systems.

Combining AI With Autonomous UV-C Disinfection

One of the company’s most visible applications combines AI-driven automation with UV-C disinfection technology.

Healthcare-associated infections remain a persistent issue across hospitals worldwide. According to data cited by the company from the CDC, these infections contribute to roughly 72,000 deaths annually in the United States.

Shyld AI’s autonomous system uses AI to determine when and where disinfection should occur based on real-time hospital activity. The platform can identify room turnover phases, detect procedural completion, and optimize cleaning workflows between surgeries and patient transitions.

The company also referenced a Stanford University study published in the American Journal of Infection Control, which found that the system reduced contamination levels by more than 93% compared to a control room.

Agentic AI Expands Into the Physical World

The funding arrives amid growing investor interest in “agentic AI” — systems capable not only of analyzing information, but also taking autonomous action in dynamic environments.

While much of the current AI market remains focused on software copilots and generative interfaces, a growing number of startups are attempting to bring AI into physical operational settings such as manufacturing, robotics, logistics, and healthcare infrastructure.

Hospitals represent one of the most challenging environments for this type of deployment. They combine strict regulatory requirements, highly variable workflows, privacy constraints, and constant operational pressure. Successfully deploying autonomous AI systems in those settings could signal broader opportunities for physical AI systems across other regulated industries.

Shyld AI says it plans to use the new funding to expand deployments across U.S. healthcare systems while also exploring applications in pharmaceutical manufacturing and regulated cleanroom environments.

The broader implication is that healthcare AI may increasingly evolve beyond digital assistants and administrative tools toward systems that directly interact with and optimize the physical environment itself.